Advair HFA 230-21 MCG inhaler 12GM
Ended Awarded Last action
- Contract number
- SPE2DR26FHR0C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,004
Award facts
- Contract value 100% obligated
- $10,003.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Advair HFA 230-21 microgram inhalers (12 grams) with a contract ceiling value of $10,003.65 and an ultimate completion date of January 7, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.999999 billion through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Through its various contract awards with the Defense Logistics Agency, the company supplies a broad portfolio of pharmaceutical products including brand-name and generic medications, specialty drugs, vaccines, and medical supplies across multiple therapeutic domains. The company's demonstrated capability to compete successfully on a full and open basis and efficiently fulfill government pharmaceutical supply requirements makes it well-suited for the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FHR0C?
SPE2DR26FHR0C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FHR0C worth?
The government has obligated $10,004 on SPE2DR26FHR0C.
Is contract SPE2DR26FHR0C an order under another contract?
Yes. SPE2DR26FHR0C is a delivery order under SPE2DR25D1041, an indefinite delivery contract.
Was contract SPE2DR26FHR0C competed?
The extent of competition for SPE2DR26FHR0C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award